The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases
Open accessThe DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Interleukin-17 (IL-17) induces the production of granulocyte colony-stimulating factor (G-CSF) and chemokines such as CXCL1 and CXCL2 and is a cytokine that acts as an inflammation mediator. During infection, IL-17 is needed to eliminate extracellular bacteria and fungi, by inducing antimicrobial peptides such as defensin. This cytokine also plays an important role in chronic inflammation that occurs during the pathogenesis of autoimmune diseases and allergies such as human rheumatoid arthritis (RA) for which a mouse model of collagen-induced arthritis (CIA) is available. In autoimmune diseases such as RA and multiple sclerosis (MS), IL-17 is produced by helper T (Th) cells that are stimulated by IL-1 β and IL-6 derived from phagocytes such as macrophages and from tissue cells. IL-17 contributes to various lesions that are produced by Th17 cells, one subset of helper T cells, and by γδ T cells and innate lymphoid cells. It strongly contributes to autoimmune diseases that are accompanied by chronic inflammation. Thus, a functional understanding of Th17 cells is extremely important. In this review, we highlight the roles of cytokines that promote the development and maintenance of pathogenic Th17 cells in autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many physical disorders have been reported to increase the risk for developing a depressive disorder (125) and to activate the production of pro-inflammatory cytokines.”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [159]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 1×
“Among molecules that contribute to the maturation and function of Th17 cells, ROR𝛾t has DNA binding sites and ligand binding regions, and therefore it is thought to be easy to focus on the targeted sites.”
BackgroundAstrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265 · cited 1×
“IFN-𝛾 strongly activates macrophages, promoting the elimination of intracellular pathogens.”
BackgroundIL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 1×
“Studies using mice lacking p19 shed light on the role of helper T cells in EAE [13, 54].”
BackgroundVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Research works printed but not linked: 1
- 2009, Science Signaling, 2
Cited by
Candida albicans—The Virulence Factors and Clinical Manifestations of Infection
Talapko, J., Juzbašić, M., Matijević, T., Pustijanac, E., Bekić, S., Kotris, I., & Škrlec, I. (2021) · Journal of Fungi · doi:10.3390/jof7020079 · Cited by 794
Moving towards personalized treatments of immune-related adverse events
Esfahani, K., Elkrief, A., Calabrese, C., Lapointe, R., Hudson, M., Routy, B., Miller, W. H., & Calabrese, L. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0352-8 · Cited by 351
The role of autoantibodies in the pathophysiology of rheumatoid arthritis
Derksen, V. F. A. M., Huizinga, T. W. J., & van der Woude, D. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0627-z · Cited by 327
Cytokine Research in Depression: Principles, Challenges, and Open Questions
Himmerich, H., Patsalos, O., Lichtblau, N., Ibrahim, M. A. A., & Dalton, B. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00030 · Cited by 313
The Role of Natural Killer Cells in Autoimmune Diseases
Kucuksezer, U. C., Aktas Cetin, E., Esen, F., Tahrali, I., Akdeniz, N., Gelmez, M. Y., & Deniz, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.622306 · Cited by 284
Fatigue, Sleep, and Autoimmune and Related Disorders
Zielinski, M. R., Systrom, D. M., & Rose, N. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01827 · Cited by 254
Role of gut microbiota in infectious and inflammatory diseases
Maciel-Fiuza, M. F., Muller, G. C., Campos, D. M. S., do Socorro Silva Costa, P., Peruzzo, J., Bonamigo, R. R., Veit, T., & Vianna, F. S. L. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1098386 · Cited by 233
Immunoporosis: Role of Innate Immune Cells in Osteoporosis
Saxena, Y., Routh, S., & Mukhopadhaya, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.687037 · Cited by 222
The role of the gut microbiome in shaping the immune system of chickens
Broom, L. J., & Kogut, M. H. (2018) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2018.10.002 · Cited by 191
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies
Davis, J. S., Ferreira, D., Paige, E., Gedye, C., & Boyle, M. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00035-19 · Cited by 187
Autophagy and proinflammatory cytokines: Interactions and clinical implications
Ge, Y., Huang, M., & Yao, Y.-M. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.07.001 · Cited by 186
Musolino, C., Allegra, A., Innao, V., Allegra, A. G., Pioggia, G., & Gangemi, S. (2017) · Mediators of Inflammation · doi:10.1155/2017/1852517 · Cited by 168
Fungal keratitis: Pathogenesis, diagnosis and prevention
Niu, L., Liu, X., Ma, Z., Yin, Y., Sun, L., Yang, L., & Zheng, Y. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103802 · Cited by 167
Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases
Chen, J., Liu, X., & Zhong, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.566922 · Cited by 165
Macrophages in pancreatitis: Mechanisms and therapeutic potential
Hu, F., Lou, N., Jiao, J., Guo, F., Xiang, H., & Shang, D. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110693 · Cited by 163
Leiding, J. W., Vogel, T. P., Santarlas, V. G. J., Mhaskar, R. S., Smith, M. R., Carisey, A. F., Vargas‐Hernández, A., Silva‐Carmona, M., Heeg, M., Rensing‐Ehl, A., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.09.002 · Cited by 154
Menter, A., Krueger, G. G., Paek, S. Y., Kivelevitch, D. N., Adamopoulos, I. E., & Langley, R. G. B. (2021) · Dermatology and Therapy · doi:10.1007/s13555-021-00483-2 · Cited by 142
Secukinumab: A Review in Ankylosing Spondylitis
Blair, H. A. (2019) · Drugs · doi:10.1007/s40265-019-01075-3 · Cited by 138
Blood–Brain Barrier Dysfunction in the Pathogenesis of Major Depressive Disorder
Wu, S., Yin, Y., & Du, L. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01153-9 · Cited by 137
IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid
Chakievska, L., Holtsche, M. M., Künstner, A., Goletz, S., Petersen, B., Thaçi, D., Ibrahim, S. M., Ludwig, R. J., Franke, A., Sadik, C. D., et al. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.09.003 · Cited by 133
Berry, S. P. D.-G., Dossou, C., Kashif, A., Sharifinejad, N., Azizi, G., Hamedifar, H., Sabzvari, A., & Zian, Z. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108402 · Cited by 124
Communications Between Bone Marrow Macrophages and Bone Cells in Bone Remodeling
Chen, K., Jiao, Y., Liu, L., Huang, M., He, C., He, W., Hou, J., Yang, M., Luo, X., & Li, C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.598263 · Cited by 122
The Interplay among miRNAs, Major Cytokines, and Cancer-Related Inflammation
Chakraborty, C., Sharma, A. R., Sharma, G., & Lee, S. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.04.002 · Cited by 122
Waśkiel‐Burnat, A., Osińska, M., Salińska, A., Blicharz, L., Goldust, M., Olszewska, M., & Rudnicka, L. (2021) · Cells · doi:10.3390/cells10123397 · Cited by 120
Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
Mallick, R., Basak, S., Chowdhury, P., Bhowmik, P., Das, R. K., Banerjee, A., Paul, S., Pathak, S., & Duttaroy, A. K. (2025) · Pharmaceuticals · doi:10.3390/ph18010104 · Cited by 119
Xu, M., Duan, X., Chen, Q.-Y., Fan, H., Hong, Z., Deng, S., Nan, Z., Wu, H., Dong, Y., Liu, Y., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.087 · Cited by 118
The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions
Kerkis, I., da Silva, Á. R. D. B. P., & Araldi, R. P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1400533 · Cited by 113
IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy
Johnson, D., Patel, A. B., Uemura, M. I., Trinh, V. A., Jackson, N., Zobniw, C. M., Tetzlaff, M. T., Hwu, P., Curry, J. L., & Diab, A. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0682 · Cited by 111
Progress in Niobium Oxide-Containing Coatings for Biomedical Applications: A Critical Review
Safavi, M. S., Walsh, F. C., Visai, L., & Khalil‐Allafi, J. (2022) · ACS Omega · doi:10.1021/acsomega.2c00440 · Cited by 109
Prevotella Induces the Production of Th17 Cells in the Colon of Mice
Huang, Y. C., Tang, J., Cai, Z., Zhou, K., Chang, L., Bai, Y., & Ma, Y. (2020) · Journal of Immunology Research · doi:10.1155/2020/9607328 · Cited by 99
Liang, S., Deng, X., Lei, L., Zheng, Y., Ai, J., Chen, L., Xiong, H., Mei, Z., Cheng, Y.-C., & Ren, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01466 · Cited by 95
Interactions between Gut Microbiota and Immunomodulatory Cells in Rheumatoid Arthritis
Xu, H., Zhao, H., Fan, D., Liu, M., Cao, J., Xia, Y., Ju, D., Xiao, C., & Guan, Q. (2020) · Mediators of Inflammation · doi:10.1155/2020/1430605 · Cited by 94
Koh, J., Hur, J. Y., Lee, K. Y., Kim, M. S., Heo, J. Y., Ku, B. M., Sun, J.-M., Lee, S.-H., Ahn, J. S., Park, K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76130-1 · Cited by 87
Th17/IL-17 induces endothelial cell senescence via activation of NF-κB/p53/Rb signaling pathway
Zhang, L., Liu, M., Liu, W., Hu, C., Li, H., Deng, J., Cao, Q., Wang, Y., Hu, W., & Li, Q. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00629-y · Cited by 87
Amelioration effects of α-viniferin on hyperuricemia and hyperuricemia-induced kidney injury in mice
Guo, X.-L., Gao, Y., Yang, Y.-X., Zhu, Q., Guan, H.-Y., He, X., Zhang, C., Wang, Y., Xu, G., Zou, S.-H., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154868 · Cited by 87
Putnam, N. E., Fulbright, L. E., Curry, J. M., Ford, C. A., Petronglo, J. R., Hendrix, A. S., & Cassat, J. E. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1007744 · Cited by 83
Mitra, S., Sarkar, S. D., Pradhan, A., Pati, A. K., Pradhan, R., Mondal, D., Sen, S., Ghosh, A., Chatterjee, S., & Chatterjee, M. (2017) · Free Radical Research · doi:10.1080/10715762.2017.1402303 · Cited by 83
Deckmann, I., Schwingel, G. B., Fontes‐Dutra, M., Bambini-Júnior, V., & Gottfried, C. (2018) · NeuroImmunoModulation · doi:10.1159/000492113 · Cited by 78
Molecular Mechanisms of Immune Regulation: A Review
Arneth, B. M. (2025) · Cells · doi:10.3390/cells14040283 · Cited by 77
Bu, Y., Wu, H., Deng, R., & Wang, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.733387 · Cited by 75
Secukinumab: A Review in Ankylosing Spondylitis
Blair, H. A., & Dhillon, S. (2016) · Drugs · doi:10.1007/s40265-016-0598-8 · Cited by 74
Maarouf, M., Clark, A. K., Lee, D. E., & Shi, V. Y. (2017) · Journal of Dermatological Treatment · doi:10.1080/09546634.2017.1395806 · Cited by 73
Malengier‐Devlies, B., Metzemaekers, M., Wouters, C. H., Proost, P., & Matthys, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.766620 · Cited by 73
Key Players of Hepatic Fibrosis
Dawood, R. M., El-Meguid, M. A., Salum, G. M., & Awady, M. K. E. (2020) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2020.0059 · Cited by 73
Soininen, L., Roslund, M. I., Nurminen, N., Puhakka, R., Laitinen, O. H., Hyöty, H., Sinkkonen, A., ADELE research group, Cerrone, D., Grönroos, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-10432-4 · Cited by 70
Wang, B., Zhao, C., Sun, G., Zhang, Z., Qian, B., Zhu, Y., Cai, M., Pandey, S., Zhao, D., Wang, Y., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.008 · Cited by 69
Yue, P., Jing, L., Zhao, X., Zhu, H., & Teng, J. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116731 · Cited by 68
The Yin and Yang of IL-17 in Systemic Sclerosis
Wei, L., Abraham, D., & Ong, V. H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.885609 · Cited by 67
RANK/RANKL/OPG Signaling in the Brain: A Systematic Review of the Literature
Glasnović, A., O’Mara, N., Kovačić, N., Grčević, D., & Gajović, S. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.590480 · Cited by 67
Involvement of IL-17 in Secondary Brain Injury After a Traumatic Brain Injury in Rats
Tan, L., Zhang, Y., Han, D., Hua, R., Guo, B., Hu, S.-Q., Yan, X., & Xu, T. J. (2017) · NeuroMolecular Medicine · doi:10.1007/s12017-017-8468-4 · Cited by 67
Mesenchymal stem cell therapy for neurological disorders: The light or the dark side of the force?
Isaković, J., Šerer, K., Barišić, B., & Mitrečić, D. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1139359 · Cited by 66
Circadian clock genes as promising therapeutic targets for autoimmune diseases
Xiang, K., Xu, Z., Hu, Y., He, Y.-S., Wu, G., Li, T., Wang, X., Ding, L., Zhang, Q., Tao, S., et al. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102866 · Cited by 65
Tian, X., Wei, W., Cao, Y., Ao, T., Huang, F., Javed, R., Wang, X., Fan, J., Zhang, Y., Liu, Y., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17086 · Cited by 64
Bamola, V. D., Dubey, D., Samanta, P., Kedia, S., Ahuja, V., Madempudi, R. S., Neelamraju, J., & Chaudhry, R. (2022) · Anaerobe · doi:10.1016/j.anaerobe.2022.102652 · Cited by 64
Acharjee, S., Verbeek, M., Gomez, C. D., Bisht, K., Lee, B., Benoit, L., Sharkey, K. A., Benediktsson, A., Tremblay, M.-E., & Pittman, Q. J. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.0398-18.2018 · Cited by 63
Bajić, S. S., Đokić, J., Dinić, M., Tomić, S., Popović, N., Brdarić, E., Golić, N., & Tolinački, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-58177-2 · Cited by 62
Molano‐González, N., Rojas, M., Monsalve, D. M., Pacheco, Y., Acosta‐Ampudia, Y., Rodríguez, Y., Rodríguez‐Jiménez, M., Ramírez-Santana, C., & Anaya, J. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.11.002 · Cited by 61
A contemporary review on pathogenesis and immunity of COVID-19 infection
Mirzaei, R., Karampoor, S., Sholeh, M., Moradi, P., Ranjbar, R., & Ghasemi, F. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05621-1 · Cited by 60
Lebwohl, M., Deodhar, A. A., Griffiths, C. E. M., Menter, A., Poddubnyy, D., Bao, W., Jehl, V., Marfo, K., Primatesta, P., Shete, A., et al. (2021) · British Journal of Dermatology · doi:10.1111/bjd.20136 · Cited by 60
The pleiotropic role of interleukin-17 in atherosclerosis
Allam, G. A., Abdel‐Moneim, A., & Gaber, A. M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.110 · Cited by 60
Moon, J., Lee, S.-Y., Choi, J. W., Lee, A. R., Yoo, J. H., Moon, S., Park, S., & Cho, M. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02860-z · Cited by 60
Reschke, R., Enk, A. H., & Hassel, J. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126532 · Cited by 59
Jianqing, X., Ren, Z., Cao, K., Li, X., Yang, J., Luo, X., Zhu, L., Wang, X., Ding, L., Liang, J., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.789242 · Cited by 58
Shibabaw, T., Teferi, B., & Ayelign, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1094823 · Cited by 57
A comprehensive network map of IL-17A signaling pathway
Balaya, R. D. A., Dagamajalu, S., Gouda, M. M., Suchitha, G. P., Chanderasekaran, J., Raju, R., Prasad, T. S. K., & Bhandary, Y. P. (2022) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-022-00686-y · Cited by 57
POOLMAN, J. T. (2020) · npj Vaccines · doi:10.1038/s41541-020-00232-0 · Cited by 57
Yadav, K., Soni, A., Singh, D., & Singh, M. R. (2021) · Progress in Biomaterials · doi:10.1007/s40204-021-00154-7 · Cited by 56
Relationship between gut microbiota and rheumatoid arthritis: A bibliometric analysis
Dong, Y., Yao, J., Deng, Q., Li, X., He, Y., Ren, X., Zheng, Y., Song, R., Zhong, X., Ma, J., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1131933 · Cited by 55
Kynurenic Acid/AhR Signaling at the Junction of Inflammation and Cardiovascular Diseases
Grishanova, A. Y., & Perepechaeva, M. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136933 · Cited by 55
Serum levels of IL-17 are elevated in patients with acute gouty arthritis
Liu, Y., Zhao, Q., Yin, Y., McNutt, M. A., Zhang, T., & Cao, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.166 · Cited by 55
Inflammasome and Its Therapeutic Targeting in Rheumatoid Arthritis
Jiang, Q., Wang, X., Huang, E., Wang, Q., Wen, C., Yang, G., Lu, L., & Cui, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.816839 · Cited by 55
The role of the gut microbiota in schizophrenia: Current and future perspectives
Rodrígues-Amorím, D., Baltanás, T. R., Regueiro, B. J., Spuch, C., Heras, M. E. D. L., Méndez, R. V.-N., Nieto-Araujo, M., Barreiro-Villar, C., Olivares, J. M., & Agís‐Balboa, R. C. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1433878 · Cited by 54
Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions
Abdelmoaty, M. M., Yeapuri, P., Machhi, J., Olson, K. E., Shahjin, F., Kumar, V. S., Zhou, Y., Liang, J., Pandey, K., Acharya, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.741502 · Cited by 54
IL-17 in type II diabetes mellitus (T2DM) immunopathogenesis and complications; molecular approaches
Elahi, R., Nazari, M., Mohammadi, V., Esmaeilzadeh, K., & Esmaeilzadeh, A. (2024) · Molecular Immunology · doi:10.1016/j.molimm.2024.03.009 · Cited by 53
Valenzuela, L. M., Draibe, J. B., Fulladosa, X., Bestard, O., Cruzado, J. M., & Ambrós, J. T. (2019) · Clinical Kidney Journal · doi:10.1093/ckj/sfz029 · Cited by 53
Shields, C. A., McCalmon, M. L., Ibrahim, T., White, D. L., Williams, J. M., LaMarca, B. B., & Cornelius, D. C. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00061.2018 · Cited by 52
LACC1 Regulates TNF and IL-17 in Mouse Models of Arthritis and Inflammation
Skon-Hegg, C., Zhang, J., Wu, X., Sagolla, M. S., Ota, N., Wüster, A., Tom, J. A., Doran, E., Ramamoorthi, N., Caplazi, P., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800636 · Cited by 52
Radu, A.-F., Ţiţ, D. M., Endres, L. M., Radu, A.-F., Vesa, C. M., & BUNGAU, S. G. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01602-z · Cited by 51
The Role of IL-17A in Mediating Inflammatory Responses and Progression of Neurodegenerative Diseases
Zheng, M., & Luo, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062505 · Cited by 49
Sisto, M., Lorusso, L., Ingravallo, G., Ribatti, D., & Lisi, S. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-0373-z · Cited by 49
Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534
Xue, X., Leon-Tabaldo, A. D., Luna-Roman, R., Castro, G., Albers, M., Schoetens, F., DePrimo, S. E., Devineni, D., Wilde, T. C., Goldberg, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90497-9 · Cited by 49
Ji, W., Peng, X. X., Lou, T. L., Wang, J., & Qiu, W. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00599-0 · Cited by 49
Association of immune cell recruitment and BPD development
Heydarian, M., Schulz, C., Stoeger, T., & Hilgendorff, A. (2022) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-022-00148-w · Cited by 48
Cytokine-targeting biologics for allergic diseases
Lawrence, M. G., Steinke, J. W., & Borish, L. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2018.01.009 · Cited by 48
He, R., Lao, Y., Yu, W., Zhang, X., Jiang, M., & Zhu, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.764618 · Cited by 48
Neuronal Cell Adhesion Molecules May Mediate Neuroinflammation in Autism Spectrum Disorder
Eve, M., Gandawijaya, J., Yang, L., & Oguro‐Ando, A. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.842755 · Cited by 47
Tamiya, S., Yoshikawa, E., Ogura, M., Kuroda, E., Suzuki, K., & Yoshioka, Y. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01588-21 · Cited by 47
Leva, G., Klein, C., Benyounes, J., Hallé, F., Bihel, F. J. ‐., Collongues, N., Seze, J. D., Mensah‐Nyagan, A. G., & Patte‐Mensah, C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.09.007 · Cited by 47
Role of NLRP3 inflammasome in liver disease
Mamun, A. A., Akter, A., Hossain, S., Sarker, T., Safa, S. A., Mustafa, Q. G., Muhammad, S. A., & Munir, F. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12918 · Cited by 47
Lv, Z., Guo, M. Z., Zhao, X., Shao, Y., Zhang, W., & Li, C. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100047 · Cited by 46
Lee, Y., Ishikawa, T., Lee, H., Lee, B., Ryu, C., Mejia, I. D., Kim, M., Lu, G., Hong, Y., Feng, M., et al. (2025) · Cell · doi:10.1016/j.cell.2025.03.006 · Cited by 46
Immune checkpoint inhibitors and vasculitis
Boland, P. M., Heath, J. L., & Sandigursky, S. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000672 · Cited by 46
Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease
von Essen, M. R., Hellem, M. N. N., Vinther‐Jensen, T., Ammitzbøll, C., Hansen, R. H., Hjermind, L. E., Nielsen, T. T., Nielsen, J. E., & Sellebjerg, F. (2020) · Annals of Neurology · doi:10.1002/ana.25647 · Cited by 45
Fang, S., Huang, Y., Liu, X., Zhong, S., Wang, N., Zhao, B., Li, Y., Sun, J. P., Wang, Y., Zhang, S., et al. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24008 · Cited by 45
The Role of Flavonoids in Inhibiting Th17 Responses in Inflammatory Arthritis
Kelepouri, D., Mavropoulos, Α., Bogdanos, D. P., & Sakkas, L. I. (2018) · Journal of Immunology Research · doi:10.1155/2018/9324357 · Cited by 45
Interleukin-17: A potential therapeutic target in COVID-19
Mendoza, V. M. M. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.072 · Cited by 45
Pathogenesis Markers of Hashimoto's Disease—A Mini Review
Jin, B., Wang, S., & Fan, Z. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2710297 · Cited by 44
Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patients
Li, Y., Guptill, J. T., Russo, M. A., Massey, J. M., Juel, V. C., Hobson‐Webb, L. D., Howard, J. F., Chopra, M., Liu, W., & Yi, J. S. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.11.006 · Cited by 44
Peck, M. M., Maram, R., Mohamed, A. A., Crespo, D. O., Kaur, G., Ashraf, I., & Malik, B. H. (2020) · Cureus · doi:10.7759/cureus.10276 · Cited by 43
Nemirovsky, A., Ilan, K., Lerner, L., Cohen-Lavi, L., Schwartz, D., Goren, G., Sergienko, R., Greenberg, D., Slonim‐Nevo, V., Sarid, O., et al. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100407 · Cited by 42
Metadata
- Authors
- Kuwabara, T., Ishikawa, F., Kondo, M., & Kakiuchi, T.
- Affiliations
- Toho University (JP)
- Corresponding author
- Kuwabara, Taku
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2017
- Volume
- 2017
- Pages
- 1-11
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC5337858
- OpenAlex
- W2590668924
- Cited by
- 519
- References
- 115
- Citations by year
- 2026: 31 · 2025: 60 · 2024: 62 · 2023: 49 · 2022: 72 · 2021: 75 · 2020: 69 · 2019: 45 · 2018: 42 · 2017: 13
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Japan Society for the Promotion of Science (25460600)
- Takeda Science Foundation (25460600)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- IL-17, Th17 cells, autoimmune disease, rheumatoid arthritis, multiple sclerosis, chronic inflammation, T helper cells, γδ T cells, innate lymphoid cells, granulocyte colony-stimulating factor, CXCL1, CXCL2, antimicrobial peptides, collagen-induced arthritis, IL-1β, interleukin-6, macrophages
- MeSH terms
- Animals, Autoimmune Diseases, Humans, Inflammation, Models, Biological, Cytokines, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.